# Pediatrix Medical (MD) — Earnings

MD · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/md/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $0.63 |
| EPS estimate | $0.59 |
| EPS surprise | +6.60% |
| Revenue surprise | +1.94% |
| Revenue | $487.8M |
| Revenue estimate | $478.5M |
| Reported | Aug 4, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/893949/000119312526331513/md-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/372be8d1-d4a2-1676-9672-0753779c8706.html) |

Pediatrix reported Q2 2026 results on August 4, 2026. Earnings per share came in at $0.63, ahead of the $0.59 estimate by 6.60%. Revenue of $487.8 million beat the $478.5 million consensus by 1.94%. Compared with Q2 2025, EPS rose about 19% from $0.53 and revenue rose about 4% from $468.8 million.

Annual EPS in the table fell from $1.67 in 2022 to $1.26 in 2023, then recovered to $1.49 in 2024 and $2.03 in 2025. The first half of 2026 adds up to $1.07, about 24% more than the $0.86 of a year earlier. Revenue has stayed in a narrow band, between $458.4 million and $513.8 million a quarter across the table. Q1 was the weakest quarter of each complete year shown, and the EPS high here is $0.67 in Q3 2025. Pediatrix beat the EPS estimate in 13 of the last 20 quarters, including 7 of the last 8.

Pediatrix reported Q3 between October 28 and November 3 in each of the past five years. That points to late October or early November 2026 for the next report. It will show whether the year-over-year EPS gains of the first half carry into the third quarter.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 4, 2026 | $0.59 | $0.63 | 6.60% | $478.5M | $487.8M |
| Q1 2026 | May 5, 2026 | $0.38 | $0.44 | 15.85% | $465.8M | $476.2M |
| Q4 2025 | Feb 19, 2026 | $0.54 | $0.50 | -7.03% | $486.2M | $493.8M |
| Q3 2025 | Nov 3, 2025 | $0.47 | $0.67 | 43.96% | $476.4M | $492.9M |
| Q2 2025 | Aug 5, 2025 | $0.42 | $0.53 | 24.74% | $464.4M | $468.8M |
| Q1 2025 | May 6, 2025 | $0.24 | $0.33 | 36.65% | $451.4M | $458.4M |
| Q4 2024 | Feb 20, 2025 | $0.37 | $0.51 | 38.81% | $486.2M | $502.4M |
| Q3 2024 | Nov 1, 2024 | $0.37 | $0.44 | 19.70% | $498.9M | $511.2M |
| Q2 2024 | Aug 6, 2024 | $0.31 | $0.34 | 8.70% | $505.5M | $504.3M |
| Q1 2024 | May 7, 2024 | $0.18 | $0.20 | 8.70% | $497.9M | $495.1M |
| Q4 2023 | Feb 20, 2024 | $0.33 | $0.32 | -1.54% | $523.3M | $496.4M |
| Q3 2023 | Nov 2, 2023 | $0.44 | $0.32 | -26.44% | $507.6M | $506.6M |
| Q2 2023 | Aug 3, 2023 | $0.40 | $0.39 | -3.01% | $495.9M | $501.0M |
| Q1 2023 | May 2, 2023 | $0.23 | $0.23 | 0.48% | $490.7M | $491.0M |
| Q4 2022 | Feb 17, 2023 | $0.48 | $0.47 | -2.91% | $502.0M | $513.8M |
| Q3 2022 | Nov 3, 2022 | $0.54 | $0.40 | -26.44% | $511.8M | $489.9M |
| Q2 2022 | Aug 4, 2022 | $0.47 | $0.47 | -0.49% | $491.5M | $486.0M |
| Q1 2022 | Apr 28, 2022 | $0.27 | $0.33 | 21.28% | $474.2M | $482.2M |
| Q4 2021 | Feb 17, 2022 | $0.44 | $0.52 | 19.27% | $483.9M | $498.5M |
| Q3 2021 | Oct 28, 2021 | $0.41 | $0.46 | 10.87% | $480.3M | $492.9M |

## Frequently Asked Questions

### When did Pediatrix Medical (MD) last report earnings?

Pediatrix Medical last reported on Aug 4, 2026, covering fiscal Q2 2026.

### Did MD beat earnings estimates?

Yes. Pediatrix Medical reported EPS of $0.63 for Q2 2026 against a $0.59 estimate — a 6.60% beat.

### How much revenue did MD report last quarter?

Pediatrix Medical reported $487.8M in revenue for Q2 2026, against a consensus estimate of $478.5M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).